| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA238581
Max Phase: Preclinical
Molecular Formula: C24H24N4O2
Molecular Weight: 400.48
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCN(CC)CCOc1ccc2nc3c(cc2c1)Cn1c-3nc2ccccc2c1=O
Standard InChI: InChI=1S/C24H24N4O2/c1-3-27(4-2)11-12-30-18-9-10-20-16(14-18)13-17-15-28-23(22(17)25-20)26-21-8-6-5-7-19(21)24(28)29/h5-10,13-14H,3-4,11-12,15H2,1-2H3
Standard InChI Key: HYLSGMABRPWCOT-UHFFFAOYSA-N
Associated Targets(Human)
MCF7 126967 Activities
HeLa 62764 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CCRF-CEM 65223 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CEM/C2 38 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HL-60 67320 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 400.48 | Molecular Weight (Monoisotopic): 400.1899 | AlogP: 3.69 | #Rotatable Bonds: 6 |
| Polar Surface Area: 60.25 | Molecular Species: BASE | HBA: 6 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 12.11 | CX Basic pKa: 9.30 | CX LogP: 3.72 | CX LogD: 1.82 |
| Aromatic Rings: 4 | Heavy Atoms: 30 | QED Weighted: 0.44 | Np Likeness Score: -0.79 |
References
| 1. Nacro K, Zha CC, Guzzo PR, Jason Herr R, Peace D, Friedrich TD.. (2007) Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives., 15 (12): [PMID:17418582] [10.1016/j.bmc.2007.03.067] |
Source
Source(1):